This article summarizes various scenarios for how the FDA, courts, and independent 3rd-parties may influence off-label drug promotion in the future.
Instagram may become the social medium of choice for pharma marketers now that it has been purchased by Face-book and has added several new features that allow marketers to potentially thwart FDA regulations.
Pharma Marketing News is periodic e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.
This article describes how Boehringer Ingelheim teamed up with with Univison in a ground-breaking campaign to drive awareness for Type 2 Diabetes through story-line integrations in the original production, Bajo el Mismo Cielo (Under the Same Sky).
Trying to determine what portion of pharma's total marketing budget is devoted to digital and if that portion is increasing, is a daunting task.
This article summarizes several comments submitted to the FDA in response to the agency's proposed study of animation in direct-to-consumer drug ads.
Welcome to Vol. 15, Issue No. 1 (JANUARY 2016) of Pharma Marketing News. New Drug Approvals, FDA Enforcement Actions, 2016 New Year's Resolution, and Digitally Savvy Women Pharma Pioneers are the themes of this issue.
Brand name drug mascots not only appear in TV and print ads, they also are plastered all over patient education brochures and other marketing pieces, on websites, and wherever else there are eyeballs! This article features our all-time favorite drug ad mascots.
2016 is an election year and therefore it's important that pharma has appropriate New Year's Resolutions to counteract the bad press it's likely to receive.
This article explores the trend in direct-to-consumer (DTC) ads for 'breakthrough' cancer therapies.